The Hyderabad-based Granules India Ltd has commenced the commercial production at its 100 per cent export oriented API plant situated at Bonthapally, Medak District of Andhra Pradesh. The unit has a manufacturing capacity of 8000 TPA of Paracetamol.
The new facility, built as per the US FDA norms, is aimed to augment production of the company in the OTC and prescription markets in the US, Europe and other regulated markets.
The company is also developing a tableting unit at Gagillapur, which is likely to be commissioned by the first quarter of the next fiscal year. The unit will have a state-of-the-art compression and coating unit and an automatic packaging facility.
The company aims to offer one-stop solution to pharmaceutical companies, from the manufacture of several strategic APIs to multiple PFIs to finished dosages of tablets and capsules.